Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."
Andrew is a partner in the Patents & Innovation team and offers expert counsel on contentious patent and regulatory matters.
Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector and is recognised by clients for his extensive industry knowledge.
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53
Intellectual Property: patents (contentious & non-contentious) - "Andrew has been identified as a key name to note."
by Dr Paul England and Andrew Payne
Dealing with difficult service in the UPC: The cases of Philips IP Ventures v Belkin and Panasonic v Xiaomi as examples.
by multiple authors
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
by Andrew Payne
by multiple authors
by Katie Chandler and Esha Marwaha
by multiple authors
by multiple authors
by multiple authors
by multiple authors